Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: A potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia

Virchows Archiv

Volumn 450, Issue 5, 2007, Pages 539-547

  Moritani, Suzuko ^a   Ichihara, Shu ^a   Kushima, Ryoji ^b   Okabe, Hidetoshi ^b   Bamba, Masamichi ^c   Kobayashi, Tadao K ^c   Hattori, Takanori ^b  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Medical Care Center   (Japan)

Author keywords

Intraductal papilloma; Myoepithelial cell; Neuroendocrine differentiation; Solid intraductal papillary carcinoma; Usual ductal hyperplasia

Indexed keywords

BIOCHEMICAL MARKER; CALPONIN; CHROMOGRANIN; CYTOKERATIN; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST HYPERPLASIA; BREAST PAPILLOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOEPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KERATINS; MAMMARY GLANDS, HUMAN; MIDDLE AGED; MOLECULAR WEIGHT; NERVE TISSUE PROTEINS; PAPILLOMA, INTRADUCTAL; TUMOR MARKERS, BIOLOGICAL;

EID: 34247622336     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0402-y     Document Type: Article

References (23)

1. Ali-Fehmi R, Carolin K, Wallis T, Visscher DW (2003) Clinicopathologic analysis of breast lesions associated with multiple papillomas. Human Pathol 34:234-239
2. Boecker W, Buerger H, Schmitz K, Ellis IA, van Diest PJ, Sinn HP, Geradts J, Diallo R, Poremba C, Herbs H (2001) Ductal epithelial proliferations of the breast: biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 195:415-421
3. Capella C, Eusebi V, Mann B, Azzopardi JG (1980) Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 4:613-630
4. Diallo R, Schaefer H, Poremba C, Shivazi N, Willmann V, Buerger H, Dockhorn-Dworniczak B, Boecker W (2001) Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J Pathol 193:27-32
5. Douglas-Jones A, Shah V, Morgan J, Dallimore N, Rashid M (2005) Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63. Histopathology 47:202-208
6. Going JJ (2003) Stages on the way to breast cancer. J Pathol 199:1-3
7. Gudjonsson T, Rønnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW (2002) Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 115:39-50
8. Hill CB, Yeh IT (2005) Myoepithelial cell staining patterns of papillary breast lesions. From intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol 123:36-44
9. Ichihara S, Fujimoto T, Hashimoto K, Moritani S, Hasegawa M, Yokoi T (2007) Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast. Pathol Int 57:126-132
10. Jarasch ED, Nagle RB, Kaufmann M, Maurer C, Böcker W (1988) Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Human Pathol 19:276-289
11. Lefkowitz M, Usar CM, Lefkowitz W, Wargotz ES (1994) Intraductal(intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases. Human Pathol 25:802-809
12. MacGrogan G, Tavassoli FA (2003) Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch 443:609-617
13. Maluf HM, Koerner FC (1995) Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol 19:1237-1244
14. Maluf HM, Zukerberg LR, Dickersin GR, Koerner FC (1991) Spindle-cell argyrophilic mucin-producing carcinoma of the breast. Histological, ultrastructural, and immunohistochemical studies of two cases. Am J Surg Pathol 15:677-686
15. Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi TK, Hattori T (2002) Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol 15:397-405
16. Nassar H, Qureshi H, VolkanAdsay N, Visscher D (2006) Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 30:501-507
17. Papotti M, Gugliotta P, Eusebi V, Bussolati G (1983) Immunohistochemical analysis of benign and malignant papillary lesions of the breast. Am J Surg Pathol 7:451-461
18. Purcell CA, Norris HJ (1998) Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions. Ann Diagn Pathol 2:135-145
19. Rabban JT, Koerner FC, Lerwill ME (2006) Solid papillary carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin5/6. Human Pathol 37:787-793
20. Raju UB, Zarbo RJ, Crissman JD (1989) Papillary neoplasm of the breast: Immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms. Mod Pathol 2:569-576
21. Tavassoli FA (1999) Papillary lesions. In: Pathology of the breast, 2nd edn. McGraw-Hill, New York, NY, pp 325-371
22. Tavassoli FA, Devilee P (eds) (2003) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC, Lyon, pp 76-80
23. Tse GM, Tan PH, Lui PCW, Gilks B, Poon CSP, Ma TKF, Law BKB, Lam WWM (2006) The role of immunohistochemistry for smooth muscle actin, p63, CD10 and CK14 in the differential diagnosis of papillary lesions of the breast. J Clin Pathol 12:(Epub ahead of print)